CHARLES BORUM: Open Payments
NPI 1417042979 · NATCHEZ, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$269 in 10 payments from 10 companies in 2025. Trend: 2023 $339 · 2024 $100 · 2025 $269
Food & beverage: $269
| Company | Payments | Amount |
|---|---|---|
| Phathom Pharmaceuticals, Inc. | 1 | $83 |
| Merck Sharp & Dohme LLC | 1 | $30 |
| ABBVIE INC. | 1 | $24 |
| ABIOMED | 1 | $22 |
| Abbott Laboratories | 1 | $21 |
| Exact Sciences Corporation | 1 | $21 |
| Astellas Pharma US Inc | 1 | $18 |
| Currax Pharmaceuticals LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $15 |
Products named: VOQUEZNA, VERQUVO, QULIPTA, FREESTYLE LIBRE 3, Cologuard Collection Kit, Veozah, CONTRAVE, BREZTRI.
Industry payments across MS — which companies pay providers there.
